MedStar Health News

Absorb™ Stent Opens Clogged Arteries, then Gradually Dissolves in the Body Washington, D.C., August 30, 2016 – A heart stent that slowly dissolves into the body is now available for patients with clo...

The first clinical trial to test a newly approved breast cancer drug specifically in African American patients is now enrolling at Georgetown Lombardi Comprehensive Cancer Center and will begin soon at five other institutions in Washington, DC, Maryland, Alabama and New Jersey.

The first clinical trial to compare standard of care chemotherapy with molecularly tailored therapy (also known as precision medicine) for metastatic pancreatic cancer is now enrolling patients at Georgetown Lombardi Comprehensive Cancer Center.

Barbara S. Bregman, PhD, senior research scientist and director of education and training with MedStar NRH Research Division, and a professor in the Departments of Neuroscience and Rehabilitation Medicine at Georgetown University Medical Center and the Center for Brain Plasticity at Georgetown University, is the recipient of the 28th Annual John W. Goldschmidt Award.

In 2013 at the age of 53, Semple, a healthy trialthlete, was diagnosed with advanced cancer of the thymus, a small gland in the neck that produces T cells for the immune system.

The Memory Disorders Program at Georgetown University is seeking volunteers to participate in an international clinical trial of a drug that, in an early phase study, has demonstrated promise in slowing mental decline in Alzheimer’s disease.